Asian equities refuse to follow the US lead
The perpetual mega-bulls of the US stock market had their day in the sun finally overnight as US indexes moved sharply higher as the armchair epidemiologists of day trading decided that omicron, while contagious, will be mild symptomatically. The S&P 500 jumped 1.42% higher, with the Nasdaq rising by 0.83%, while the Dow Jones leapt by 1.83%. In Asia, some short-term profit-taking is evident as the news wires turn slightly sour in Asia, futures on all three indexes edging around 0.15% lower.
With US equity futures markets unable to maintain upward momentum today, tier-1 US data due this evening, virus nerves and concerns reappearing around China property and China US-delisting worries, Asian markets have mostly rallied, but only modestly so. The Nikkei 225 has climbed by 0.35%, with the Kospi climbing by 0.45%. Mainland China sees the Shanghai Composite 0.55% higher, with the CSI 300 rising by 0.35%. Hong Kong is in the red, though, as China property nerves sap sentiment. The Hang Seng has fallen by 0.65%.
Across the region, Singapore is 0.25% higher, with Kuala Lumpur up 0.30%, while Jakarta has fallen by 0.30%. Manila has jumped by 1.05%, with Bangkok down 0.15% and Taipei unchanged for the session. Australian markets have recorded cautious gains, the All Ordinaries edging 0.10% higher and the ASX 200 gaining 0.20%.
European markets will likely unwind some of yesterday’s losses, but gains will be limited ahead of the US Non-Farm Payrolls. As ever this week, the street is one negative omicron headline away from turning sharply lower en masse. If the virus news ticker stays quiet, a higher US Non-Farm Payrolls print could see equity gains capped, with a slightly lower or on target print of 550K, not enough to entirely remove faster Fed-taper fears.